$Amicus Therapeutics (FOLD.US)$ Announces Topline Results fr...
$Amicus Therapeutics(FOLD.US$ Announces Topline Results from Phase 2b GALACTIC-1 Trial of GB0139 for the Treatment of Idiopathic Pulmonary Fibrosis.
GALACTIC-1 trial did not meet its primary endpoint.
Galecto to discontinue the development of GB0139.
GALACTIC-1 trial did not meet its primary endpoint.
Galecto to discontinue the development of GB0139.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
I’m instinct based traders , I hate reading charts !
My prediction is magic!
6336Followers
136Following
187KVisitors
Follow